title: Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes.
abstract: An HIV-1 vaccine able to induce broad CD4+ and CD8+ T cell responses may provide long-term control of viral replication. In this study we directly assess the relative benefit of immunization with vaccines expressing three structural Ags (Gag, Pol, and Env), three early regulatory proteins (Rev, Tat, and Nef), or a complex vaccine expressing all six Ags. The simultaneous administration of all six Ags during vaccination resulted in Ag competition manifested by a relative reduction of CD8+ T cell and lymphoproliferative responses to individual Ags. Despite the Ag competition, vaccination with all six Ags resulted in a delay in the onset and a decrease in the extent of acute viremia after mucosal challenge exposure to highly pathogenic SIV(mac251). Reduced levels of acute viremia correlated with lower post-set point viremia and long-term control of infection. In immunized animals, virus-specific CD4+ T cell and lymphoproliferative responses were preserved during acute viremia, and the maintenance of these responses predicted the long-term virological outcome. Taken together, these results suggest that the breadth of the immune response is probably more important than high frequency responses to a limited number of epitopes. These data provide the first clear evidence of the importance of nonstructural HIV Ags as components of an HIV-1 vaccine.
authors.affiliation: Animal Models and Retroviral Vaccines Section, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Hel
authors.forename: Wen-Po
authors.initials: WP
authors.lastname: Tsai
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Tryniszewska
authors.forename: Janos
authors.initials: J
authors.lastname: Nacsa
authors.forename: Phillip D
authors.initials: PD
authors.lastname: Markham
authors.forename: Mark G
authors.initials: MG
authors.lastname: Lewis
authors.forename: George N
authors.initials: GN
authors.lastname: Pavlakis
authors.forename: Barbara K
authors.initials: BK
authors.lastname: Felber
authors.forename: Jim
authors.initials: J
authors.lastname: Tartaglia
authors.forename: Genoveffa
authors.initials: G
authors.lastname: Franchini
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000276:immunology*; D005814:Genes, Viral / Q000276:immunology*; D008253:Macaca mulatta; D018449:SAIDS Vaccines / Q000627:therapeutic use*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000187:drug effects / Q000235:genetics*; D013601:T-Lymphocytes / Q000821:virology; D014766:Viremia / Q000188:drug therapy
chemical_list: D000956:Antigens, Viral; D018449:SAIDS Vaccines